Advertisement

Topics

Schering-Plough Corporation Company Profile

16:48 EDT 25th September 2017 | BioPortfolio


News Articles [84 Associated News Articles listed on BioPortfolio]

Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma

  Life Sciences Jobs   ...

Merck, Upsher-Smith to pay $60 mln in 'pay-for-delay' drug case

Merck & Co Inc and Upsher-Smith Laboratories Inc have agreed to pay $60.2 million to resolve a lawsuit that said they entered into a deal to unlawfully delay the availability of generic versions o...

Caret Pharma To Acquire Fiber Choice®

BOCA RATON, Fla., Aug. 21, 2017 /PRNewswire/ -- Caret Pharma, a subsidiary of Caret Group, today announced it has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Ch...

Prometheus Announces New Chief Commercial Officer

SAN DIEGO, Feb. 3, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the appointment of Anthony J. Yost as Senior Vice Presiden...

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Anisindione Market: By Strategic AnalysisValue Chain, Pricing, Opportunities Analysis, Others, By Type, By ApplicationAnticoagulant, Protein Hydrolysis, Others, By Services, By Surgery GeographyForecast 20162021 [Updated: 22012016] Prices from USD $5250

Anisindione also know with the brand name Miradon, is an artificial anticoagulant and a derivative of indanedione. Anisindione helps in preventing the formation of active procoagulation factors II, VI...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 ...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Nutrient loads from agricultural and forested areas in Finland from 1981 up to 2010-can the efficiency of undertaken water protection measures seen?

Long-term data from a network of intensively monitored research catchments in Finland was analysed. We studied temporal (1981-2010) and spatial variability in nitrogen (N) and phosphorus (P), from 198...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Aim: to observe the graft versus tumor effect of Pegylated Interferonα-2b in patients with hematological malignancies relapsed after allogeneic hematopoietic stem cell transplantation (al...

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Bioequivalence study comparing test Acotral® ezetimibe 10 mg tablet manufactured by Laboratorios Phoenix, with a reference comparator Zetia® ezetimibe 10 mg tablet of Merck/Schering-Plou...

Remicade Infusion Management Program (Study P04466)

Schering Canada plans to collect data on about 3000 to 5000 infliximab infusions per year, starting in the third quarter of 2005. It is expected that about 12 sites from the Remicade Infu...

Companies [208 Associated Companies listed on BioPortfolio]

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering-Plough

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each ...

Schering-Plough Corporation

Schering-Plough HealthCare Products, Inc.

More Information about "Schering-Plough Corporation" on BioPortfolio

We have published hundreds of Schering-Plough Corporation news stories on BioPortfolio along with dozens of Schering-Plough Corporation Clinical Trials and PubMed Articles about Schering-Plough Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schering-Plough Corporation Companies in our database. You can also find out about relevant Schering-Plough Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record